News

• Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors
  07/08/2020 / 14:05 - GlobeNewswire
•  
• Novartis Agrees to Pay $678 Million to Settle Allegations of Illegal Kickbacks Involving Several of the Company's Cardiovascular Drugs
  07/02/2020 / 02:28 - GlobeNewswire
•  
• SEC Charges Novartis AG with FCPA Violations
  06/25/2020 / 18:51 - Newsfile Corp
•  
• Novartis' net sales jump 11% to $12.28B in Q1
  04/28/2020 / 07:05 - TeleTrader
•  
• US accepts 30M doses of hydroxychloroquine by Novartis
  03/30/2020 / 01:53 - TeleTrader
•  
• Novartis CEO: Too soon to say if malaria drug helps COVID-19
  03/27/2020 / 11:40 - TeleTrader
•  
• Novartis to donate 130M doses of hydroxychloroquine
  03/20/2020 / 17:15 - TeleTrader
•  
• Novartis Q4 EPS down to $0.5
  01/29/2020 / 07:07 - TeleTrader
•  
• Novartis nears deal to acquire Medicines - report
  11/23/2019 / 20:54 - TeleTrader
•  
• Novartis' net sales up 10% to $12.17B in Q3
  10/22/2019 / 07:03 - TeleTrader
•  
• ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  09/25/2019 / 17:20 - GlobeNewswire
•  
• SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
  09/23/2019 / 16:23 - GlobeNewswire
•  
• ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  09/18/2019 / 17:40 - GlobeNewswire
•  
• SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
  09/13/2019 / 16:15 - GlobeNewswire
•  
• Glancy Prongay & Murray LLP Continues its Investigation on Behalf of Novartis AG Investors (NVS)
  09/11/2019 / 22:30 - GlobeNewswire